NCT04991779

Brief Summary

A diagnostic accuracy study on Artificial intelligence assisted continue EEG diagnostic tool is to carried out comparing with manually EEG interpretation as the golden standard for neonatal seizure.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2022

Shorter than P25 for all trials

Geographic Reach
1 country

3 active sites

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 5, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

March 16, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 16, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 16, 2022

Completed
Last Updated

December 29, 2023

Status Verified

December 1, 2023

Enrollment Period

2 months

First QC Date

July 28, 2021

Last Update Submit

December 27, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • The accuracy of AI-assisted cEEG diagnostic tool in evaluating the neonatal seizure

    The accuracy of includes sensitivity and specificity. The reference standard is the electrographic seizures interpreted by 3 clinicians who had attended the uniformly training program and were certified by the Chinese Anti-Epilepsy Association. Sensitivity is defined as: The proportion of neonates with seizures is successfully screened out by AI-assisted cEEG diagnostic tool. Specificity is defined as: The proportion of neonates without seizures who are not recognized as seizures by AI-assisted cEEG diagnostic tool.

    within 7 days since the end of cEEG monitoring during hospitalization

Study Arms (1)

The neonates with suspected seizures or high risk of seizures

The neonates with suspected seizures or high risk of seizures are monitored by continuous electroencephalogram (cEEG) at least 12 hours since admission. The cEEG will be interpreted by AI-assisted cEEG diagnostic tool at the end of cEEG monitoring. At the same time, the same cEEG will be manually reported according the reference standard.

Diagnostic Test: AI-assisted cEEG detection tool

Interventions

This study is an observational study to evaluate the accuracy of AI-assisted cEEG diagnostic tool with routine care. All patients from the cohort accept cEEG monitoring and AI-assisted cEEG detection tool. The tool included a quantitive EEG neural signal processing pipeline to extract features from the original signal datasets, machine learning models based on gradient boosted model for prediction. The reference standard is the electrographic seizures interpreted by 3 clinicians who had attended the uniformly training program and were certified by the Chinese Anti-Epilepsy Association.

The neonates with suspected seizures or high risk of seizures

Eligibility Criteria

Age0 Days - 28 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Neonates with suspected seizures and high risk of seizures

You may qualify if:

  • Postnatal age \< or = 28 days;
  • cEEG monitoring at least 12hours monitoring;
  • Suspected seizures;
  • Risk of Intracranial hemorrhage;
  • Abnormality of MRI or ultrasound before cEEG;
  • Neonates diagnosed with encephalopathy or suspected of encephalopathy;
  • Hypoxic-ischemic encephalopathy or suspected hypoxic-ischemic encephalopathy;
  • Metabolic disturbances (Hypoglycemia, Hypocalcemia, Hypomagnesemia, Inborn errors of metabolism);
  • Central nervous system (CNS) or systemic infections;
  • Postsurgical neonatal within 3 days;
  • Suspected genetic disease or Positive genetic diagnoses;

You may not qualify if:

  • The neonates with head scalp defect, scalp hematoma, edema and other contraindications which are not suitable for cEEG monitoring during hospitalization.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Henan Children's Hospital

Zhengzhou, Henan, China

Location

Children Hospital of Fudan University

Shanghai, Shanghai Municipality, 201102, China

Location

Chengdu Women's and Children's Central Hospital

Chengdu, Sichuan, China

Location

Related Publications (3)

  • Rennie JM, de Vries LS, Blennow M, Foran A, Shah DK, Livingstone V, van Huffelen AC, Mathieson SR, Pavlidis E, Weeke LC, Toet MC, Finder M, Pinnamaneni RM, Murray DM, Ryan AC, Marnane WP, Boylan GB. Characterisation of neonatal seizures and their treatment using continuous EEG monitoring: a multicentre experience. Arch Dis Child Fetal Neonatal Ed. 2019 Sep;104(5):F493-F501. doi: 10.1136/archdischild-2018-315624. Epub 2018 Nov 24.

  • Shellhaas RA, Chang T, Tsuchida T, Scher MS, Riviello JJ, Abend NS, Nguyen S, Wusthoff CJ, Clancy RR. The American Clinical Neurophysiology Society's Guideline on Continuous Electroencephalography Monitoring in Neonates. J Clin Neurophysiol. 2011 Dec;28(6):611-7. doi: 10.1097/WNP.0b013e31823e96d7. No abstract available.

  • Hoodbhoy Z, Masroor Jeelani S, Aziz A, Habib MI, Iqbal B, Akmal W, Siddiqui K, Hasan B, Leeflang M, Das JK. Machine Learning for Child and Adolescent Health: A Systematic Review. Pediatrics. 2021 Jan;147(1):e2020011833. doi: 10.1542/peds.2020-011833. Epub 2020 Dec 15.

Study Officials

  • Wenhao Zhou, Ph.D

    Children's Hospital of Fudan University

    STUDY CHAIR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2021

First Posted

August 5, 2021

Study Start

March 16, 2022

Primary Completion

May 16, 2022

Study Completion

May 16, 2022

Last Updated

December 29, 2023

Record last verified: 2023-12

Locations